Green Health & Wellness US FDA approves first drug for fatty liver disease NASH – GWC Mag gwcmagMarch 28, 2024053 views Health 14 March 2024, 2:54 pm 1 minute Reuters was first to report on the FDA approving Madrigal Pharmaceuticals’ drug Rezdiffra, an oral drug to treat a fatty liver disease known as non-alcoholic steatohepatitis (NASH). The approval was the first of its kind. Market Impact The company’s shares surged 24% in extended trading. Article Tags Topics of Interest: Health Type: Reuters Best Sectors: Pharmaceuticals & Healthcare Regions: Americas Countries: United States Win Types: Speed Story Types: Exclusive / Scoop Media Types: Text Customer Impact: Significant National Story